Qt 5 Inc (932127) SEC Filing 8-K Material Event for the period ending Monday, November 15, 2004

Addison Davis Diagnostics

CIK: 932127

View differences made from one to another to evaluate Addison Davis Diagnostics's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Addison Davis Diagnostics.


Assess how Addison Davis Diagnostics's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Addison Davis Diagnostics's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 932127
Form Type: 8-K Corporate News
Accession Number: 0001144204-04-020198
Submitted to the SEC: Mon Nov 22 2004 7:59:15 PM EST
Accepted by the SEC: Tue Nov 23 2004
Period: Monday, November 15, 2004
Industry: Pharmaceutical Preparations
  1. Accountant Change
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: